Lantern Pharma, Inc. (LTRN)
1.97
+0.10
(+5.35%)
USD |
NASDAQ |
Apr 10, 16:00
2.00
+0.03
(+1.52%)
After-Hours: 20:00
Lantern Pharma Free Cash Flow : -15.68M for Dec. 31, 2025
Free Cash Flow Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Free Cash Flow Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Free Cash Flow Benchmarks
| Vertex Pharmaceuticals, Inc. | 3.194B |
| BioVie, Inc. | -14.32M |
| Acurx Pharmaceuticals, Inc. | -6.788M |
| ACADIA Pharmaceuticals, Inc. | 6.308M |
| Alnylam Pharmaceuticals, Inc. | 465.38M |
Free Cash Flow Related Metrics
| Cash from Operations (Quarterly) | -2.792M |
| Cash from Investing (Quarterly) | -1.704M |
| Cash from Financing (Quarterly) | 0.5265M |
| Free Cash Flow Per Share (Quarterly) | -0.2481 |
| Free Cash Flow to Equity (Quarterly) | -2.777M |
| Free Cash Flow to Firm (Quarterly) | -2.792M |
| Free Cash Flow Yield | -72.92% |